Analytical Data
-
Gene name
TECTb
- Application
-
Alternative Names
TECTb；Beta-tectorin
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q96PL2
-
Expression Region
1-304aa
-
AA Sequence
MVTKAFVLLA IFAEASAKSC APNKADVILV FCYPKTIITK IPECPYGWEV HQLALGGLCY NGVHEGGYYQ FVIPDLSPKN KSYCGTQSEY KPPIYHFYSH IVSNDTTVIV KNQPVNYSFS CTYHSTYLVN QAAFDQRVAT VHVKNGSMGT FESQLSLNFY TNAKFSIKKE APFVLEASEI GSDLFAGVEA KGLSIRFKVV LNSCWATPSA DFMYPLQWQL INKGCPTDET VLVHENGRDH RATFQFNAFR FQNIPKLSKV WLHCETFICD SEKLSCPVTC DKRKRLLRDQ TGGVLVVELS LRSR
-
Molecular Weight
34 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of TECTb recombinant protein is rooted in its significance within the field of molecular biology and immunology. TECTb, or T-cell extinction protein, has emerged as a critical focus due to its role in modulating immune responses and maintaining T-cell homeostasis. Abnormal expression or function of TECTb has been linked to various autoimmune diseases and cancers, prompting researchers to investigate its molecular mechanisms and biological implications. Recombinant protein technology allows for the effective production and purification of TECTb, facilitating detailed studies of its structure-function relationship. Understanding TECTb's interactions with other proteins and its signaling pathways can provide insights into how T-cell activation and regulation are controlled. Moreover, utilizing TECTb as a therapeutic target holds potential for developing innovative treatments for diseases characterized by immune dysregulation. As research progresses, the exploration of TECTb recombinant protein not only enhances our knowledge of T-cell biology but also opens new avenues for therapeutic interventions in immunological disorders.
